 |
Weekly
news bulletin |
| |
We have received some very positive feedback
about Glycosmedia. One re-occurring suggestion is for a weekly
news service. This is top of our “to do” list just as soon as we can attract sufficient sponsorship funding. If you know
of any funding streams then please do get in touch with us (Jim Young, Editor) |
| |
|
|
Diabetes
Web Resources on the YHPHO Website |
| |
The Yorkshire
and Humber Public Health Observatory have updated their online diabetes pages, allowing you easier access to the
full range of tools/products they have available. Along with
signposting to their most recent products, there is a full alphabetical
listing of all current diabetes related resources (NDST, UK) |
| |
|
|
Treating
Diabetes in Custody |
| |
Pioneering work by NHS Lothian to ensure that
people with diabetes in police custody receive suitable care has
reduced the number of emergency referrals of prisoners to hospital
(All Media Scotland, UK) |
| |
|
|
Why
and When to Implement Incretin Therapy |
| |
This article describes the rationale for the
use of GLP-1 receptor agonists and DPP-4 inhibitors in patients
with type 2 diabetes mellitus (T2DM) in whom they might be especially
useful (Medscape) |
| |
|
|
Call
for Research Group Proposals - October 2008 |
| |
Eligibility criteria (Diabetes Research Network,
UK) |
| |
|
|
Maternal
Enterovirus Infection during Pregnancy as a Risk Factor in Offspring
Diagnosed with Type 1 Diabetes between 15 and 30 Years of Age |
| |
These results suggest that gestational enterovirus
infections may be related to the risk of offspring developing type
1 diabetes in adolescence and young adulthood (Experimental Diabetes
Research) |
| |
|
|
Role
of C-Peptide in the Regulation of Microvascular Blood Flow |
| |
There is increasing evidence, that in patients
with declining beta cell function, the lack of C-peptide secretion
might play a putative role in the development of microvascular
blood flow abnormalities, which go beyond the effects of declining
insulin secretion or increased blood glucose levels (Experimental
Diabetes Research) |
| |
|
|
Development
of a diabetes treatment simulation model: with application to
assessing alternative treatment intensification strategies on
survival and diabetes-related complications |
| |
The objective of this analysis is to project
the long-term impacts on life expectancy and occurrence over 5,
10, and 40 years of microvascular and macrovascular complications
of diabetes when using different haemoglobin A1c (HbA1c) thresholds
for intensifying treatment of type 2 diabetes (PubMed) |
| |
|
|
Putative
environmental-endocrine disruptors and obesity: a review |
| |
Data demonstrate migration of endocrine disruptors
in the environment and are beginning to catalogue their effects
on adiposity (Current Opinion in Endocrinology, Diabetes & Obesity) |
| |
|
